138 related articles for article (PubMed ID: 20201714)
1. Cytochrome P450 2D6 polymorphism and drug utilization in patients with oral lichen planus.
Paulusová V; Rösch C; Drízhal I; Perlík F; Masín V; Sukumar S; Slezák R; Slanar O
Acta Odontol Scand; 2010 Jul; 68(4):193-8. PubMed ID: 20201714
[TBL] [Abstract][Full Text] [Related]
2. Ultrarapid metabolism of sparteine: frequency of alleles with duplicated CYP2D6 genes in a Danish population as determined by restriction fragment length polymorphism and long polymerase chain reaction.
Bathum L; Johansson I; Ingelman-Sundberg M; Hørder M; Brøsen K
Pharmacogenetics; 1998 Apr; 8(2):119-23. PubMed ID: 10022749
[TBL] [Abstract][Full Text] [Related]
3. Can the genotype or phenotype of two polymorphic drug metabolising cytochrome P450-enzymes identify oral lichenoid drug eruptions?
Kragelund C; Hansen C; Reibel J; Nauntofte B; Brosen K; Jensen SB; Torpet LA
J Oral Pathol Med; 2010 Jul; 39(6):497-505. PubMed ID: 20492431
[TBL] [Abstract][Full Text] [Related]
4. Polymorphic drug metabolizing CYP-enzymes--a pathogenic factor in oral lichen planus?
Kragelund C; Hansen C; Reibel J; Nauntofte B; Broesen K; Pedersen AM; Smidt D; Eiberg H; Torpet LA
J Oral Pathol Med; 2009 Jan; 38(1):63-71. PubMed ID: 19192051
[TBL] [Abstract][Full Text] [Related]
5. Development of a PCR-based strategy for CYP2D6 genotyping including gene multiplication of worldwide potential use.
Dorado P; Cáceres MC; Pozo-Guisado E; Wong ML; Licinio J; Llerena A
Biotechniques; 2005 Oct; 39(4):571-4. PubMed ID: 16235570
[TBL] [Abstract][Full Text] [Related]
6. Increased frequency of cytochrome P450 2D6 poor metabolizers among patients with metoprolol-associated adverse effects.
Wuttke H; Rau T; Heide R; Bergmann K; Böhm M; Weil J; Werner D; Eschenhagen T
Clin Pharmacol Ther; 2002 Oct; 72(4):429-37. PubMed ID: 12386645
[TBL] [Abstract][Full Text] [Related]
7. Changes in the QTc interval after administration of flecainide acetate, with and without coadministered paroxetine, in relation to cytochrome P450 2D6 genotype: data from an open-label, two-period, single-sequence crossover study in healthy Korean male subjects.
Lim KS; Jang IJ; Kim BH; Kim J; Jeon JY; Tae YM; Yi S; Eum S; Cho JY; Shin SG; Yu KS
Clin Ther; 2010 Apr; 32(4):659-66. PubMed ID: 20435235
[TBL] [Abstract][Full Text] [Related]
8. Concordance of P450 2D6 (debrisoquine hydroxylase) phenotype and genotype: inability of dextromethorphan metabolic ratio to discriminate reliably heterozygous and homozygous extensive metabolizers.
Evans WE; Relling MV
Pharmacogenetics; 1991 Dec; 1(3):143-8. PubMed ID: 1688245
[TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetics and CYP2D6 genotypes do not predict metoprolol adverse events or efficacy in hypertension.
Zineh I; Beitelshees AL; Gaedigk A; Walker JR; Pauly DF; Eberst K; Leeder JS; Phillips MS; Gelfand CA; Johnson JA
Clin Pharmacol Ther; 2004 Dec; 76(6):536-44. PubMed ID: 15592325
[TBL] [Abstract][Full Text] [Related]
10. Rapid and reliable genotyping procedure for detection of alleles with mutations, deletion, or/and duplication of the CYP2D6 gene.
Arneth B; Shams M; Hiemke C; Härtter S
Clin Biochem; 2009 Aug; 42(12):1282-90. PubMed ID: 19393232
[TBL] [Abstract][Full Text] [Related]
11. Genetic polymorphism of CYP2D6 in the Japanese population.
Chida M; Yokoi T; Kosaka Y; Chiba K; Nakamura H; Ishizaki T; Yokota J; Kinoshita M; Sato K; Inaba M; Aoki Y; Gonzalez FJ; Kamataki T
Pharmacogenetics; 1999 Oct; 9(5):601-5. PubMed ID: 10591540
[TBL] [Abstract][Full Text] [Related]
12. Effect of tolterodine on sleep structure modulated by CYP2D6 genotype.
Diefenbach K; Jaeger K; Wollny A; Penzel T; Fietze I; Roots I
Sleep Med; 2008 Jul; 9(5):579-82. PubMed ID: 17921051
[TBL] [Abstract][Full Text] [Related]
13. Subgrouping of patients with oral lichen planus according to cytochrome P450 enzyme phenotype and genotype.
Kragelund C; Jensen SB; Hansen Cand Scient C; Broesen K; Torpet LA; Reibel J
Oral Surg Oral Med Oral Pathol Oral Radiol; 2014 Oct; 118(4):469-74. PubMed ID: 25240994
[TBL] [Abstract][Full Text] [Related]
14. Matrix metalloproteinase gene expression in oral lichen planus: erosive vs. reticular forms.
Mazzarella N; Femiano F; Gombos F; De Rosa A; Giuliano M
J Eur Acad Dermatol Venereol; 2006 Sep; 20(8):953-7. PubMed ID: 16922944
[TBL] [Abstract][Full Text] [Related]
15. Serotonin transporter gene polymorphism (5-HTTLPR) in patients with oral lichen planus.
Perdigão PF; Guimarães AL; Victoria JM; Xavier GM; Romano-Silva MA; Gomez RS
Arch Oral Biol; 2007 Sep; 52(9):889-93. PubMed ID: 17359932
[TBL] [Abstract][Full Text] [Related]
16. DNA polymorphisms and tissue cyclooxygenase-2 expression in oral lichen planus: a case-control study.
Abdel Hay RM; Fawzy MM; Metwally D; Kadry D; Ezzat M; Rashwan W; Rashed LA
J Eur Acad Dermatol Venereol; 2012 Sep; 26(9):1122-6. PubMed ID: 21923838
[TBL] [Abstract][Full Text] [Related]
17. Development of a PCR-based strategy for CYP2D6 genotyping including gene multiplication of worldwide potential use.
Dorado P; Cáceres M; Pozo-Guisado E; Wong ML; Licinio J; Llerena A
Biotechniques; 2005 Oct; 39(10 Suppl):S571-4. PubMed ID: 18957039
[TBL] [Abstract][Full Text] [Related]
18. Polymorphism of tumor protein p53 codon 72 showed no association with oral lichen planus in Shiraz, Iran.
Ghabanchi J; Fattahi MJ; Mardani M; Tadbir AA; Paydar AA
J Craniofac Surg; 2009 Nov; 20(6):2168-70. PubMed ID: 19884837
[TBL] [Abstract][Full Text] [Related]
19. Frequency of single nucleotide polymorphisms of CYP2D6 in the Czech population.
Buzková H; Pechandová K; Slanar O; Perlík F
Cell Biochem Funct; 2008; 26(1):76-81. PubMed ID: 17311358
[TBL] [Abstract][Full Text] [Related]
20. Micronuclear and sister chromatid exchange analyses in peripheral lymphocytes of patients with oral lichen planus--a pilot study.
Ergun S; Warnakulasuriya S; Duman N; Saruhanoğlu A; Sevinç B; Oztürk S; Ozel S; Cefle K; Palanduz S; Tanyeri H
Oral Dis; 2009 Oct; 15(7):499-504. PubMed ID: 19500270
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
